-
EP1453522
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1453522
| EP1453522 - METHODS FOR TREATMENT OR PROPHYLAXIS OF ALDOSTERONE-MEDIATED PATHOGENIC EFFECTGS IN A SUBJECT USING AN EPOXY-STEROIDAL ALDOSTERONE ANTAGONIST [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.10.2007 Database last updated on 02.08.2024 | Most recent event Tooltip | 26.10.2007 | Application deemed to be withdrawn | published on 28.11.2007 [2007/48] | Applicant(s) | For all designated states Pharmacia Corporation 100 Route 206 North Peapack, NJ 07977 / US | [2007/15] |
| Former [2004/37] | For all designated states Pharmacia Corporation P.O. Box 1027 St. Louis, Missouri 63006 / US | Inventor(s) | 01 /
WILLIAMS, Gordon, H. 86 Munroe Street Belmont, MA 02478 / US | 02 /
FUNDER, John, W. Commercial Road Victoria, Australia 3181 / AU | 03 /
GARTHWAITE, Susan, M. 901 Hinman Avenue Evanston, IL 60202 / US | 04 /
RONIKER, Barbara 1530 North Dearborn Parkway Chicago, IL 60610 / US | 05 /
FEDDE, Kenton, N. 339 Sylvester Webster Groves, MO 63119 / US | 06 /
ROCHA, Ricardo 5314 George Court, Apt. A Gurnee, IL 60031 / US | [2004/37] | Representative(s) | Wood, David John Pfizer Limited European Patents Department, Ramsgate Road, Sandwich Kent CT13 9NJ / GB | [N/P] |
| Former [2004/37] | Wood, David John Pfizer Limited European Patents Department, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | Application number, filing date | 01998044.0 | 13.12.2001 | [2004/37] | WO2001US48419 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03051372 | Date: | 26.06.2003 | Language: | EN | [2003/26] | Type: | A1 Application with search report | No.: | EP1453522 | Date: | 08.09.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.06.2003 takes the place of the publication of the European patent application. | [2004/37] | Search report(s) | International search report - published on: | EP | 26.06.2003 | Classification | IPC: | A61K31/585, A61P5/42 | [2004/37] | CPC: |
A61K31/585 (EP,KR);
A61K31/569 (KR);
A61K31/58 (KR);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P25/00 (EP);
A61P25/06 (EP);
A61P3/10 (EP);
A61P5/28 (EP);
A61P5/42 (EP);
A61P7/10 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
A61P9/12 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/37] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | BEHANDLUNG- ODER VORBEUGUNGSMETHODEN VON ALDOSTERONBEDINGTEN PATHOGENEN WIRKUNGEN DURCH EPOXYSTEROIDALDOSTERONANTAGONISTEN | [2004/37] | English: | METHODS FOR TREATMENT OR PROPHYLAXIS OF ALDOSTERONE-MEDIATED PATHOGENIC EFFECTGS IN A SUBJECT USING AN EPOXY-STEROIDAL ALDOSTERONE ANTAGONIST | [2004/37] | French: | METHODES DESTINEES A TRAITER OU PREVENIR DES EFFETS PATHOGENES INDUITS PAR L'ALDOSTERONE CHEZ UN SUJET AU MOYEN D'UN ANTAGONISTE D'ALDOSTERONE EPOXY-STEROIDIEN | [2004/37] | Entry into regional phase | 17.06.2004 | National basic fee paid | 17.06.2004 | Designation fee(s) paid | 17.06.2004 | Examination fee paid | Examination procedure | 11.07.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 17.06.2004 | Examination requested [2004/37] | 09.06.2005 | Despatch of a communication from the examining division (Time limit: M06) | 06.12.2005 | Reply to a communication from the examining division | 25.01.2007 | Despatch of a communication from the examining division (Time limit: M04) | 05.06.2007 | Application deemed to be withdrawn, date of legal effect [2007/48] | 09.07.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/48] | Fees paid | Renewal fee | 03.09.2004 | Renewal fee patent year 03 | 25.10.2004 | Renewal fee patent year 04 | 02.01.2006 | Renewal fee patent year 05 | 02.01.2007 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 13.07.2004 | 03 M06 Fee paid on 03.09.2004 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0033847 (SEARLE & CO [US], et al) [X] 1-5,19-26 * page 2, line 7 - line 15 * * page 5, line 18 - line 24 *; | [E]WO0195892 (PHARMACIA CORP [US], et al) [E] 1-26 * page 9, line 27 - page 10, line 9 * * page 22, line 28 - page 24, line 3 * * table I *; | [X] - EPSTEIN M ET AL, "EPLERENONE A NEW SELECTIVE ALDOSTERONE RECEPTOR ANTAGONIST (SARA): EFFICACY IN PATIENTS WITH MILD TO MODERATE HYPERTENSION", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, WILLIAMS AND WILKINS, BALTIMORE, MD, US, (199809), vol. 9, ISSN 1046-6673, XP001003077 [X] 1-5,19-22 * Abstract A1640 * | [X] - EPSTEIN M ET AL, "EPLERENONE, A NOVEL AND SELECTIVE ALDOSTERONE RECEPTOR ANTAGONIST: EFFICACY IN PATIENTS WITH MILD TO MODERATE HYPERTENSION", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, (19981027), vol. 98, no. 17, SUPPL, ISSN 0009-7322, XP001001544 [X] 1-5,15-22 * Abstract 498 * | [X] - RABASSEDA X ET AL, "ANTIHYPERTENSIVE TREATMENT OF HEART FAILURE ALDOSTERONE ANTAGONIST", DRUGS OF THE FUTURE, BARCELONA, ES, (1999), vol. 24, no. 5, ISSN 0377-8282, pages 488 - 501, XP001001569 [X] 1-26 * page 495, column R, line 14 - page 498, column L, line 11 * * page 499, column R, line 11 - page 500, column R, line L * DOI: http://dx.doi.org/10.1358/dof.1999.024.05.526908 | [A] - ROCHA R ET AL, "MINERALOCORTICOID BLOCKADE REDUCES VASCULAR INJURY IN STROKE-PRONE HYPERTENSIVE RATS", HYPERTENSION, (199801), vol. 31, no. 1, PART 2, ISSN 0194-911X, pages 451 - 458, XP001027834 [A] 1-14 * abstract * * page 455, column L, line 5 - column R, line 3 * |